PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs

BACKGROUNDS: Epidermal growth factor receptor (EGFR) mutation profiles play a vital role in treatment strategy decisions for non–small cell lung cancer (NSCLC). The purpose of this study was to evaluate the predictive efficacy of baseline (18)F-FDG PET/CT-based radiomics analysis for EGFR mutation s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Liping, Xu, Panpan, Li, Mengyue, Wang, Menglu, Peng, Mengye, Zhang, Ying, Wu, Tingting, Chu, Wenjie, Wang, Kezheng, Meng, Hongxue, Zhang, Lingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253544/
https://www.ncbi.nlm.nih.gov/pubmed/35800046
http://dx.doi.org/10.3389/fonc.2022.894323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253544/
https://www.ncbi.nlm.nih.gov/pubmed/35800046
http://dx.doi.org/10.3389/fonc.2022.894323

Ejemplares similares